Age‐dependent effects of diabetes and obesity on liver‐related events in non‐alcoholic fatty liver disease: Subanalysis of CLIONE in Asia

Background and Aim Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver‐related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non‐alcoholic fatty liver disease (NAFLD). Methods We performed a suban...

Full description

Saved in:
Bibliographic Details
Published inJournal of gastroenterology and hepatology Vol. 37; no. 12; pp. 2313 - 2320
Main Authors Seko, Yuya, Kawanaka, Miwa, Fujii, Hideki, Iwaki, Michihiro, Hayashi, Hideki, Toyoda, Hidenori, Oeda, Satoshi, Hyogo, Hideyuki, Morishita, Asahiro, Munekage, Kensuke, Kawata, Kazuhito, Yamamura, Sakura, Sawada, Koji, Maeshiro, Tatsuji, Tobita, Hiroshi, Yoshida, Yuichi, Naito, Masafumi, Araki, Asuka, Arakaki, Shingo, Kawaguchi, Takumi, Noritake, Hidenao, Ono, Masafumi, Masaki, Tsutomu, Yasuda, Satoshi, Tomita, Eiichi, Yoneda, Masato, Tokushige, Akihiro, Kamada, Yoshihiro, Takahashi, Hirokazu, Ueda, Shinichiro, Aishima, Shinichi, Sumida, Yoshio, Okanoue, Takeshi, Itoh, Yoshito, Nakajima, Atsushi
Format Journal Article
LanguageEnglish
Published Australia Wiley Subscription Services, Inc 01.12.2022
Subjects
Online AccessGet full text
ISSN0815-9319
1440-1746
1440-1746
DOI10.1111/jgh.16019

Cover

Abstract Background and Aim Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver‐related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non‐alcoholic fatty liver disease (NAFLD). Methods We performed a subanalysis of a retrospective cohort study (CLIONE in Asia), including 1395 patients with biopsy‐proven NAFLD. The median follow‐up was 4.6 years. Results The median age was 57 years, and 36.2% had T2DM. The median body mass index (BMI) was 27.4, and 28.5% were severely obese (BMI ≥ 30). During follow‐up, 37 patients developed hepatocellular carcinoma (HCC), and 58 patients developed LRE. In patients younger than 65 years, advanced fibrosis (hazard ratio [HR] 7.69, P < 0.001) and T2DM (HR 3.37, P = 0.017) were HCC risk factors, and advanced fibrosis (HR 9.40, P < 0.001) and T2DM (HR 2.51, P = 0.016) were LRE risk factors. In patients 65 years and older, advanced fibrosis (HR 4.24, P = 0.010) and obesity (HR 4.60, P = 0.006) were HCC risk factors, and advanced fibrosis (HR 4.22, P = 0.002) and obesity (HR 4.22, P = 0.002) were LRE risk factors. Conclusion Type 2 diabetes mellitus and obesity contributed to LRE in younger and older patients, respectively, along with advanced fibrosis. Therefore, controlling T2DM in patients younger than 65 years and controlling weight in patients 65 years and older could prevent LRE. The development of age‐dependent screening and management strategies is necessary for patients with NAFLD.
AbstractList Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver-related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non-alcoholic fatty liver disease (NAFLD).BACKGROUND AND AIMOlder age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver-related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non-alcoholic fatty liver disease (NAFLD).We performed a subanalysis of a retrospective cohort study (CLIONE in Asia), including 1395 patients with biopsy-proven NAFLD. The median follow-up was 4.6 years.METHODSWe performed a subanalysis of a retrospective cohort study (CLIONE in Asia), including 1395 patients with biopsy-proven NAFLD. The median follow-up was 4.6 years.The median age was 57 years, and 36.2% had T2DM. The median body mass index (BMI) was 27.4, and 28.5% were severely obese (BMI ≥ 30). During follow-up, 37 patients developed hepatocellular carcinoma (HCC), and 58 patients developed LRE. In patients younger than 65 years, advanced fibrosis (hazard ratio [HR] 7.69, P < 0.001) and T2DM (HR 3.37, P = 0.017) were HCC risk factors, and advanced fibrosis (HR 9.40, P < 0.001) and T2DM (HR 2.51, P = 0.016) were LRE risk factors. In patients 65 years and older, advanced fibrosis (HR 4.24, P = 0.010) and obesity (HR 4.60, P = 0.006) were HCC risk factors, and advanced fibrosis (HR 4.22, P = 0.002) and obesity (HR 4.22, P = 0.002) were LRE risk factors.RESULTSThe median age was 57 years, and 36.2% had T2DM. The median body mass index (BMI) was 27.4, and 28.5% were severely obese (BMI ≥ 30). During follow-up, 37 patients developed hepatocellular carcinoma (HCC), and 58 patients developed LRE. In patients younger than 65 years, advanced fibrosis (hazard ratio [HR] 7.69, P < 0.001) and T2DM (HR 3.37, P = 0.017) were HCC risk factors, and advanced fibrosis (HR 9.40, P < 0.001) and T2DM (HR 2.51, P = 0.016) were LRE risk factors. In patients 65 years and older, advanced fibrosis (HR 4.24, P = 0.010) and obesity (HR 4.60, P = 0.006) were HCC risk factors, and advanced fibrosis (HR 4.22, P = 0.002) and obesity (HR 4.22, P = 0.002) were LRE risk factors.Type 2 diabetes mellitus and obesity contributed to LRE in younger and older patients, respectively, along with advanced fibrosis. Therefore, controlling T2DM in patients younger than 65 years and controlling weight in patients 65 years and older could prevent LRE. The development of age-dependent screening and management strategies is necessary for patients with NAFLD.CONCLUSIONType 2 diabetes mellitus and obesity contributed to LRE in younger and older patients, respectively, along with advanced fibrosis. Therefore, controlling T2DM in patients younger than 65 years and controlling weight in patients 65 years and older could prevent LRE. The development of age-dependent screening and management strategies is necessary for patients with NAFLD.
Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver-related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non-alcoholic fatty liver disease (NAFLD). We performed a subanalysis of a retrospective cohort study (CLIONE in Asia), including 1395 patients with biopsy-proven NAFLD. The median follow-up was 4.6 years. The median age was 57 years, and 36.2% had T2DM. The median body mass index (BMI) was 27.4, and 28.5% were severely obese (BMI ≥ 30). During follow-up, 37 patients developed hepatocellular carcinoma (HCC), and 58 patients developed LRE. In patients younger than 65 years, advanced fibrosis (hazard ratio [HR] 7.69, P < 0.001) and T2DM (HR 3.37, P = 0.017) were HCC risk factors, and advanced fibrosis (HR 9.40, P < 0.001) and T2DM (HR 2.51, P = 0.016) were LRE risk factors. In patients 65 years and older, advanced fibrosis (HR 4.24, P = 0.010) and obesity (HR 4.60, P = 0.006) were HCC risk factors, and advanced fibrosis (HR 4.22, P = 0.002) and obesity (HR 4.22, P = 0.002) were LRE risk factors. Type 2 diabetes mellitus and obesity contributed to LRE in younger and older patients, respectively, along with advanced fibrosis. Therefore, controlling T2DM in patients younger than 65 years and controlling weight in patients 65 years and older could prevent LRE. The development of age-dependent screening and management strategies is necessary for patients with NAFLD.
Background and Aim Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver‐related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non‐alcoholic fatty liver disease (NAFLD). Methods We performed a subanalysis of a retrospective cohort study (CLIONE in Asia), including 1395 patients with biopsy‐proven NAFLD. The median follow‐up was 4.6 years. Results The median age was 57 years, and 36.2% had T2DM. The median body mass index (BMI) was 27.4, and 28.5% were severely obese (BMI ≥ 30). During follow‐up, 37 patients developed hepatocellular carcinoma (HCC), and 58 patients developed LRE. In patients younger than 65 years, advanced fibrosis (hazard ratio [HR] 7.69, P < 0.001) and T2DM (HR 3.37, P = 0.017) were HCC risk factors, and advanced fibrosis (HR 9.40, P < 0.001) and T2DM (HR 2.51, P = 0.016) were LRE risk factors. In patients 65 years and older, advanced fibrosis (HR 4.24, P = 0.010) and obesity (HR 4.60, P = 0.006) were HCC risk factors, and advanced fibrosis (HR 4.22, P = 0.002) and obesity (HR 4.22, P = 0.002) were LRE risk factors. Conclusion Type 2 diabetes mellitus and obesity contributed to LRE in younger and older patients, respectively, along with advanced fibrosis. Therefore, controlling T2DM in patients younger than 65 years and controlling weight in patients 65 years and older could prevent LRE. The development of age‐dependent screening and management strategies is necessary for patients with NAFLD.
Background and AimOlder age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver‐related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non‐alcoholic fatty liver disease (NAFLD).MethodsWe performed a subanalysis of a retrospective cohort study (CLIONE in Asia), including 1395 patients with biopsy‐proven NAFLD. The median follow‐up was 4.6 years.ResultsThe median age was 57 years, and 36.2% had T2DM. The median body mass index (BMI) was 27.4, and 28.5% were severely obese (BMI ≥ 30). During follow‐up, 37 patients developed hepatocellular carcinoma (HCC), and 58 patients developed LRE. In patients younger than 65 years, advanced fibrosis (hazard ratio [HR] 7.69, P < 0.001) and T2DM (HR 3.37, P = 0.017) were HCC risk factors, and advanced fibrosis (HR 9.40, P < 0.001) and T2DM (HR 2.51, P = 0.016) were LRE risk factors. In patients 65 years and older, advanced fibrosis (HR 4.24, P = 0.010) and obesity (HR 4.60, P = 0.006) were HCC risk factors, and advanced fibrosis (HR 4.22, P = 0.002) and obesity (HR 4.22, P = 0.002) were LRE risk factors.ConclusionType 2 diabetes mellitus and obesity contributed to LRE in younger and older patients, respectively, along with advanced fibrosis. Therefore, controlling T2DM in patients younger than 65 years and controlling weight in patients 65 years and older could prevent LRE. The development of age‐dependent screening and management strategies is necessary for patients with NAFLD.
Author Takahashi, Hirokazu
Araki, Asuka
Sumida, Yoshio
Iwaki, Michihiro
Tobita, Hiroshi
Masaki, Tsutomu
Hayashi, Hideki
Arakaki, Shingo
Seko, Yuya
Ueda, Shinichiro
Hyogo, Hideyuki
Kawaguchi, Takumi
Yamamura, Sakura
Sawada, Koji
Tomita, Eiichi
Fujii, Hideki
Itoh, Yoshito
Morishita, Asahiro
Nakajima, Atsushi
Yoneda, Masato
Naito, Masafumi
Okanoue, Takeshi
Yasuda, Satoshi
Kamada, Yoshihiro
Aishima, Shinichi
Yoshida, Yuichi
Ono, Masafumi
Kawanaka, Miwa
Toyoda, Hidenori
Noritake, Hidenao
Tokushige, Akihiro
Kawata, Kazuhito
Oeda, Satoshi
Munekage, Kensuke
Maeshiro, Tatsuji
Author_xml – sequence: 1
  givenname: Yuya
  orcidid: 0000-0002-3658-5894
  surname: Seko
  fullname: Seko, Yuya
  organization: Kyoto Prefectural University of Medicine
– sequence: 2
  givenname: Miwa
  surname: Kawanaka
  fullname: Kawanaka, Miwa
  organization: Kawasaki Medical School
– sequence: 3
  givenname: Hideki
  surname: Fujii
  fullname: Fujii, Hideki
  email: o21717h@omu.ac.jp
  organization: Osaka Metropolitan University
– sequence: 4
  givenname: Michihiro
  orcidid: 0000-0002-7650-0699
  surname: Iwaki
  fullname: Iwaki, Michihiro
  organization: Yokohama City University Graduate School of Medicine
– sequence: 5
  givenname: Hideki
  surname: Hayashi
  fullname: Hayashi, Hideki
  organization: Gifu Municipal Hospital
– sequence: 6
  givenname: Hidenori
  orcidid: 0000-0002-1652-6168
  surname: Toyoda
  fullname: Toyoda, Hidenori
  organization: Ogaki Municipal Hospital
– sequence: 7
  givenname: Satoshi
  surname: Oeda
  fullname: Oeda, Satoshi
  organization: Saga University Hospital
– sequence: 8
  givenname: Hideyuki
  surname: Hyogo
  fullname: Hyogo, Hideyuki
  organization: Life Care Clinic Hiroshima
– sequence: 9
  givenname: Asahiro
  orcidid: 0000-0002-0760-3045
  surname: Morishita
  fullname: Morishita, Asahiro
  organization: Kagawa University
– sequence: 10
  givenname: Kensuke
  surname: Munekage
  fullname: Munekage, Kensuke
  organization: Kochi Medical School
– sequence: 11
  givenname: Kazuhito
  surname: Kawata
  fullname: Kawata, Kazuhito
  organization: Hamamatsu University School of Medicine
– sequence: 12
  givenname: Sakura
  surname: Yamamura
  fullname: Yamamura, Sakura
  organization: Kurume University School of Medicine
– sequence: 13
  givenname: Koji
  orcidid: 0000-0002-9708-4786
  surname: Sawada
  fullname: Sawada, Koji
  organization: Asahikawa Medical University
– sequence: 14
  givenname: Tatsuji
  surname: Maeshiro
  fullname: Maeshiro, Tatsuji
  organization: University of the Ryukyus Hospital
– sequence: 15
  givenname: Hiroshi
  orcidid: 0000-0003-2408-2023
  surname: Tobita
  fullname: Tobita, Hiroshi
  organization: Shimane University Hospital
– sequence: 16
  givenname: Yuichi
  surname: Yoshida
  fullname: Yoshida, Yuichi
  organization: Suita Municipal Hospital
– sequence: 17
  givenname: Masafumi
  surname: Naito
  fullname: Naito, Masafumi
  organization: Suita Municipal Hospital
– sequence: 18
  givenname: Asuka
  surname: Araki
  fullname: Araki, Asuka
  organization: Shimane University Hospital
– sequence: 19
  givenname: Shingo
  surname: Arakaki
  fullname: Arakaki, Shingo
  organization: University of the Ryukyus Hospital
– sequence: 20
  givenname: Takumi
  orcidid: 0000-0002-7064-4325
  surname: Kawaguchi
  fullname: Kawaguchi, Takumi
  organization: Kurume University School of Medicine
– sequence: 21
  givenname: Hidenao
  surname: Noritake
  fullname: Noritake, Hidenao
  organization: Hamamatsu University School of Medicine
– sequence: 22
  givenname: Masafumi
  surname: Ono
  fullname: Ono, Masafumi
  organization: Kagawa University
– sequence: 23
  givenname: Tsutomu
  surname: Masaki
  fullname: Masaki, Tsutomu
  organization: Kagawa University
– sequence: 24
  givenname: Satoshi
  surname: Yasuda
  fullname: Yasuda, Satoshi
  organization: Ogaki Municipal Hospital
– sequence: 25
  givenname: Eiichi
  surname: Tomita
  fullname: Tomita, Eiichi
  organization: Gifu Municipal Hospital
– sequence: 26
  givenname: Masato
  surname: Yoneda
  fullname: Yoneda, Masato
  organization: Yokohama City University Graduate School of Medicine
– sequence: 27
  givenname: Akihiro
  surname: Tokushige
  fullname: Tokushige, Akihiro
  organization: Kagoshima University Graduate School of Medical and Dental Sciences
– sequence: 28
  givenname: Yoshihiro
  orcidid: 0000-0001-5485-902X
  surname: Kamada
  fullname: Kamada, Yoshihiro
  organization: Osaka University
– sequence: 29
  givenname: Hirokazu
  orcidid: 0000-0002-2374-2889
  surname: Takahashi
  fullname: Takahashi, Hirokazu
  organization: Saga University Hospital
– sequence: 30
  givenname: Shinichiro
  surname: Ueda
  fullname: Ueda, Shinichiro
  organization: University of the Ryukyus
– sequence: 31
  givenname: Shinichi
  surname: Aishima
  fullname: Aishima, Shinichi
  organization: Saga University
– sequence: 32
  givenname: Yoshio
  orcidid: 0000-0002-4342-1361
  surname: Sumida
  fullname: Sumida, Yoshio
  organization: Aichi Medical University
– sequence: 33
  givenname: Takeshi
  surname: Okanoue
  fullname: Okanoue, Takeshi
  organization: Saiseikai Suita Hospital
– sequence: 34
  givenname: Yoshito
  surname: Itoh
  fullname: Itoh, Yoshito
  organization: Kyoto Prefectural University of Medicine
– sequence: 35
  givenname: Atsushi
  orcidid: 0000-0002-6263-1436
  surname: Nakajima
  fullname: Nakajima, Atsushi
  organization: Yokohama City University Graduate School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36198983$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1u3CAYRVGVqJmkXfQFKqRumoUTMMY23Y1G-atGzaLtGmH8kTBiYGpwqtnlDdJn7JOU-ckmatggoXMufNxjdOCDB4Q-UHJG8zpf3N2f0ZpQ8QZNaFWRgjZVfYAmpKW8EIyKI3Qc44IQUpGGv0VHrKaiFS2boKfpHfx9_NPDCnwPPmEwBnSKOBjcW9VBgoiV73HoINq0xsFjZx9gyNIATiXoMTxkMWLrcX5XPldOh_vgrMZGpaxs-ZwWQUX4gr-PnfLKraPd3jKb39x-u9jY02jVO3RolIvwfr-foJ-XFz9m18X89upmNp0XuqqZKMqy05pxbpqOci7Kjuo8OKdU8JpVbQ2GGkVBGda3FW04UGNUr7QpO9ZrztkJ-rzLXQ3h1wgxyaWNGpxTHsIYZdmUJctxpMropxfoIoxDnmBDVY2o67beUB_31NgtoZerwS7VsJbPX52B8x2ghxDjAEZqm1SywadBWScpkZsyZS5TbsvMxukL4zn0f-w-_bd1sH4dlF-vrnfGPyIEsR0
CitedBy_id crossref_primary_10_1186_s12876_023_02848_7
crossref_primary_10_1186_s12916_024_03315_0
crossref_primary_10_1016_j_cgh_2023_11_022
Cites_doi 10.1002/hep.29085
10.1172/JCI45887
10.1002/cncr.24982
10.1002/hep.28431
10.1007/s00535-018-1532-5
10.1158/0008-5472.CAN-06-3075
10.1007/s00592-003-0093-z
10.1016/j.jhep.2017.07.027
10.1016/j.cgh.2018.05.057
10.1007/s12072-021-10143-4
10.1007/s40618-016-0508-7
10.1210/er.2011-1015
10.1007/s00535-015-1050-7
10.1002/hep.32244
10.1136/gutjnl-2020-322786
10.1016/j.jhep.2019.06.021
10.1002/hep.31014
10.1016/S0140-6736(03)15268-3
10.1056/NEJMoa2029349
10.1002/hep.20701
10.1016/j.jhepr.2021.100305
10.1038/sj.bjc.6603932
10.1002/hep.25762
10.1016/j.ejca.2012.02.063
10.1053/j.gastro.2015.04.043
10.1136/gut.2009.199661
ContentType Journal Article
Copyright 2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd
Copyright_xml – notice: 2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
– notice: 2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd
CorporateAuthor Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG‐NAFLD)
Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD)
CorporateAuthor_xml – name: Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG‐NAFLD)
– name: Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD)
DBID AAYXX
CITATION
NPM
7T5
7U9
H94
K9.
7X8
DOI 10.1111/jgh.16019
DatabaseName CrossRef
PubMed
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed

AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1440-1746
EndPage 2320
ExternalDocumentID 36198983
10_1111_jgh_16019
JGH16019
Genre article
Journal Article
GeographicLocations Asia
GeographicLocations_xml – name: Asia
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OB
1OC
29K
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
D-I
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DTERQ
DU5
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
KMS
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WOHZO
WOQ
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
NPM
7T5
7U9
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
H94
K9.
7X8
ID FETCH-LOGICAL-c4639-22bcc355f7b15592b1c1445119563486ef1fa1eaf3d84175e1ffadacf2b3dc553
IEDL.DBID DR2
ISSN 0815-9319
1440-1746
IngestDate Thu Sep 04 16:40:08 EDT 2025
Wed Aug 13 06:24:55 EDT 2025
Wed Feb 19 02:26:33 EST 2025
Tue Jul 01 01:45:28 EDT 2025
Thu Apr 24 23:05:46 EDT 2025
Wed Jan 22 16:22:23 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords CLIONE in Asia
non-alcoholic fatty liver disease
type 2 diabetes mellitus
liver-related events
fibrosis
age
hepatocellular carcinoma
obesity
BMI
non-alcoholic steatohepatitis
Language English
License 2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4639-22bcc355f7b15592b1c1445119563486ef1fa1eaf3d84175e1ffadacf2b3dc553
Notes No funding support to this study.
The authors do not have any disclosures to report.
Ethical approval
Declaration of conflict of interest
This multicenter registry‐based historical cohort study was approved by the institutional review board of Saga University Hospital, Saga, Japan (approval no. 2020‐04‐R‐02; June 30, 2020), which waived the requirement for informed consent due to the use of preexisting data.
Financial support
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-9708-4786
0000-0002-3658-5894
0000-0002-7064-4325
0000-0002-2374-2889
0000-0002-1652-6168
0000-0002-0760-3045
0000-0002-7650-0699
0000-0002-6263-1436
0000-0001-5485-902X
0000-0003-2408-2023
0000-0002-4342-1361
OpenAccessLink https://ocu-omu.repo.nii.ac.jp/records/2019978
PMID 36198983
PQID 2747966864
PQPubID 2045136
PageCount 8
ParticipantIDs proquest_miscellaneous_2722311904
proquest_journals_2747966864
pubmed_primary_36198983
crossref_citationtrail_10_1111_jgh_16019
crossref_primary_10_1111_jgh_16019
wiley_primary_10_1111_jgh_16019_JGH16019
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2022
PublicationDateYYYYMMDD 2022-12-01
PublicationDate_xml – month: 12
  year: 2022
  text: December 2022
PublicationDecade 2020
PublicationPlace Australia
PublicationPlace_xml – name: Australia
– name: Richmond
PublicationTitle Journal of gastroenterology and hepatology
PublicationTitleAlternate J Gastroenterol Hepatol
PublicationYear 2022
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2004; 363
2019; 71
2010; 59
2021; 3
2015; 149
2015; 50
2019; 54
2017; 65
2017; 67
2019; 17
2005; 41
2021; 385
2007; 97
2016; 39
2012; 55
2012; 33
2021; 70
2021; 15
2022
2010; 116
2020; 71
2016; 64
2022; 75
2012; 48
2003; 40
2007; 67
2011; 121
e_1_2_6_10_1
e_1_2_6_19_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_12_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_16_1
e_1_2_6_21_1
e_1_2_6_20_1
e_1_2_6_9_1
Fujii H (e_1_2_6_11_1) 2022
e_1_2_6_8_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_25_1
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_22_1
e_1_2_6_28_1
e_1_2_6_27_1
e_1_2_6_26_1
References_xml – volume: 71
  start-page: 808
  year: 2020
  end-page: 819
  article-title: Effect of metabolic traits on the risk of cirrhosis and hepatocellular cancer in nonalcoholic fatty liver disease
  publication-title: Hepatology
– volume: 116
  start-page: 1938
  year: 2010
  end-page: 1946
  article-title: Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
  publication-title: Cancer
– volume: 40
  start-page: S302
  year: 2003
  end-page: S304
  article-title: Ethnic differences in abdominal visceral fat accumulation between Japanese, African‐Americans, and Caucasians: a meta‐analysis
  publication-title: Acta Diabetol.
– volume: 75
  start-page: 1420
  year: 2022
  end-page: 1428
  article-title: Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease
  publication-title: Hepatology
– volume: 41
  start-page: 1313
  year: 2005
  end-page: 1321
  article-title: Design and validation of a histological scoring system for nonalcoholic fatty liver disease
  publication-title: Hepatology
– volume: 67
  start-page: 1265
  year: 2017
  end-page: 1273
  article-title: Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy‐proven NAFLD
  publication-title: J. Hepatol.
– volume: 17
  start-page: 748
  year: 2019
  end-page: 755.e743
  article-title: Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates
  publication-title: Clin. Gastroenterol. Hepatol.
– volume: 64
  start-page: 73
  year: 2016
  end-page: 84
  article-title: Global epidemiology of nonalcoholic fatty liver disease—meta‐analytic assessment of prevalence, incidence, and outcomes
  publication-title: Hepatology
– volume: 385
  start-page: 1559
  year: 2021
  end-page: 1569
  article-title: Prospective study of outcomes in adults with nonalcoholic fatty liver disease
  publication-title: N. Engl. J. Med.
– volume: 65
  start-page: 1557
  year: 2017
  end-page: 1565
  article-title: Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis
  publication-title: Hepatology
– volume: 54
  start-page: 367
  year: 2019
  end-page: 376
  article-title: A nationwide survey on non‐B, non‐C hepatocellular carcinoma in Japan: 2011–2015 update
  publication-title: J. Gastroenterol.
– volume: 33
  start-page: 547
  year: 2012
  end-page: 594
  article-title: The role of adiponectin in cancer: a review of current evidence
  publication-title: Endocr. Rev.
– volume: 121
  start-page: 2094
  year: 2011
  end-page: 2101
  article-title: Adipose tissue remodeling and obesity
  publication-title: J. Clin. Invest.
– volume: 67
  start-page: 2497
  year: 2007
  end-page: 2507
  article-title: Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin‐mediated promotion of invasion and migration of hepatocellular carcinoma cells
  publication-title: Cancer Res.
– volume: 97
  start-page: 1005
  year: 2007
  end-page: 1008
  article-title: Overweight, obesity and risk of liver cancer: a meta‐analysis of cohort studies
  publication-title: Br. J. Cancer
– volume: 70
  start-page: 1375
  year: 2021
  end-page: 1382
  article-title: Mortality in biopsy‐confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
  publication-title: Gut
– volume: 55
  start-page: 2005
  year: 2012
  end-page: 2023
  article-title: The diagnosis and management of non‐alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
  publication-title: Hepatology
– volume: 71
  start-page: 793
  year: 2019
  end-page: 801
  article-title: The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta‐analysis
  publication-title: J. Hepatol.
– volume: 48
  start-page: 2137
  year: 2012
  end-page: 2145
  article-title: Excess body weight and the risk of primary liver cancer: an updated meta‐analysis of prospective studies
  publication-title: Eur. J. Cancer
– volume: 149
  start-page: 389
  year: 2015
  end-page: 397
  article-title: Liver fibrosis, but no other histologic features, is associated with long‐term outcomes of patients with nonalcoholic fatty liver disease
  publication-title: Gastroenterology
– volume: 50
  start-page: 364
  year: 2015
  end-page: 377
  article-title: Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
  publication-title: J. Gastroenterol.
– volume: 39
  start-page: 1365
  year: 2016
  end-page: 1376
  article-title: Insulin, insulin receptors, and cancer
  publication-title: J. Endocrinol. Invest.
– volume: 3
  year: 2021
  article-title: Epidemiology of non‐alcoholic fatty liver disease and hepatocellular carcinoma
  publication-title: JHEP Rep.
– volume: 15
  start-page: 366
  year: 2021
  end-page: 379
  article-title: The epidemiology of NAFLD and lean NAFLD in Japan: a meta‐analysis with individual and forecasting analysis, 1995–2040
  publication-title: Hepatol. Int.
– volume: 59
  start-page: 1303
  year: 2010
  end-page: 1307
  article-title: Non‐alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications
  publication-title: Gut
– volume: 363
  start-page: 157
  year: 2004
  end-page: 163
  article-title: Appropriate body‐mass index for Asian populations and its implications for policy and intervention strategies
  publication-title: Lancet
– year: 2022
  article-title: Clinical outcomes in biopsy‐proven nonalcoholic fatty liver disease patients: a multicenter registry‐based cohort study
  publication-title: Clin. Gastroenterol. Hepatol.
– ident: e_1_2_6_15_1
  doi: 10.1002/hep.29085
– ident: e_1_2_6_24_1
  doi: 10.1172/JCI45887
– ident: e_1_2_6_18_1
  doi: 10.1002/cncr.24982
– ident: e_1_2_6_4_1
  doi: 10.1002/hep.28431
– ident: e_1_2_6_8_1
  doi: 10.1007/s00535-018-1532-5
– ident: e_1_2_6_23_1
  doi: 10.1158/0008-5472.CAN-06-3075
– ident: e_1_2_6_27_1
  doi: 10.1007/s00592-003-0093-z
– ident: e_1_2_6_7_1
  doi: 10.1016/j.jhep.2017.07.027
– ident: e_1_2_6_13_1
  doi: 10.1016/j.cgh.2018.05.057
– ident: e_1_2_6_10_1
  doi: 10.1007/s12072-021-10143-4
– ident: e_1_2_6_17_1
  doi: 10.1007/s40618-016-0508-7
– ident: e_1_2_6_25_1
  doi: 10.1210/er.2011-1015
– ident: e_1_2_6_3_1
  doi: 10.1007/s00535-015-1050-7
– ident: e_1_2_6_28_1
  doi: 10.1002/hep.32244
– ident: e_1_2_6_14_1
  doi: 10.1136/gutjnl-2020-322786
– ident: e_1_2_6_9_1
  doi: 10.1016/j.jhep.2019.06.021
– ident: e_1_2_6_16_1
  doi: 10.1002/hep.31014
– ident: e_1_2_6_26_1
  doi: 10.1016/S0140-6736(03)15268-3
– ident: e_1_2_6_5_1
  doi: 10.1056/NEJMoa2029349
– ident: e_1_2_6_12_1
  doi: 10.1002/hep.20701
– ident: e_1_2_6_21_1
  doi: 10.1016/j.jhepr.2021.100305
– ident: e_1_2_6_19_1
  doi: 10.1038/sj.bjc.6603932
– ident: e_1_2_6_2_1
  doi: 10.1002/hep.25762
– start-page: S1542‐3565(22)0
  year: 2022
  ident: e_1_2_6_11_1
  article-title: Clinical outcomes in biopsy‐proven nonalcoholic fatty liver disease patients: a multicenter registry‐based cohort study
  publication-title: Clin. Gastroenterol. Hepatol.
– ident: e_1_2_6_20_1
  doi: 10.1016/j.ejca.2012.02.063
– ident: e_1_2_6_6_1
  doi: 10.1053/j.gastro.2015.04.043
– ident: e_1_2_6_22_1
  doi: 10.1136/gut.2009.199661
SSID ssj0004075
Score 2.3996565
Snippet Background and Aim Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver‐related events (LREs). We investigated the impacts...
Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver-related events (LREs). We investigated the impacts of T2DM and obesity...
Background and AimOlder age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver‐related events (LREs). We investigated the impacts...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2313
SubjectTerms Age
Biopsy
BMI
Body mass index
CLIONE in Asia
Diabetes
Diabetes mellitus (non-insulin dependent)
Fatty liver
Fibrosis
Hepatocellular carcinoma
Liver cancer
Liver diseases
liver‐related events
non‐alcoholic fatty liver disease
non‐alcoholic steatohepatitis
Obesity
Risk factors
type 2 diabetes mellitus
Title Age‐dependent effects of diabetes and obesity on liver‐related events in non‐alcoholic fatty liver disease: Subanalysis of CLIONE in Asia
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjgh.16019
https://www.ncbi.nlm.nih.gov/pubmed/36198983
https://www.proquest.com/docview/2747966864
https://www.proquest.com/docview/2722311904
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYQB9RLebVlC0Wm6qGXIGI73oSeVgt0hdoeqiJxqBT5ubsCJRWbvXDiH8Bv5JcwfiR0W5Cq3qJkHNvJjP2NPf4GoQ-GsKzQRifEZTVhRBWJYIwmWukDq7jkPET5fuOjM3Z6np0voU_tWZjAD9EtuDnL8OO1M3AhZ78b-XjilkY85WdKuePNP_r-SB3FAskuzHhZUoCeRVYhH8XTllyci_4CmIt41U84J6voZ9vUEGdysT9v5L66_oPF8T_7soZeRiCKB0Fz1tGSqTbQyte41b6Jbgdjc39z1ybJbXCM_MC1xe2CLRaVxnVILYDrCl-6IA8o5A_IGI09O9QMTytc1RXcFyEf71RhKxoo4uVx3CM6xDCIiciR4moZfoFx_tiVHsym4hU6Ozn-MRwlMXtDohjAnoQQqRSgGduXbuuTyFSlng0NPDLKcm5sakVqhKU6ZwBiTGqt0EJZIqlWWUZfo2VonNlCuOAaYA3XQsMb-pTIPrhBuSiI0lywPumhj-1_LFWkNncZNi7LzsUZT0r_gXvofSf6K_B5PCW00ypDGU16Vjr3HXzDnLMe2usegzG6HRZRmXruZABtQQ8PQOZNUKKuFspdeFpOobFeFZ6vvjz9PPIXb_9ddBu9IO5ghg-02UHLzdXcvAO41MhdbxcPmZkS9w
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRQIuvB8LBQziwCVV4zjeBHFZlZalbHtArdQLihw_tiuqpOpmL5z4B_Ab-SXM2E6gPCTELUrGsZ3M2N_Y428Anlsu8tJYk3DKaiK4LhMlRJYYbbaclrWUIcr3QE6PxN5xfrwGr_qzMIEfYlhwI8vw4zUZOC1I_2zl8xNaGyHOz0sCgQa5Xq_f_yCPEoFmF-e8PClR0yKvkI_j6YtenI1-g5gXEaufcnavw4e-sSHS5OPmqqs39adfeBz_tzc34FrEomwSlOcmrNnmFlzej7vtt-HLZG6_ff7a58ntWAz-YK1j_ZotU41hbcguwNqGnVKcBxbyZ2SsYZ4gaskWDWvaBu-rkJJ3oZlTHRbx8ixuE71kOI6pSJNCtWzPcKjfodKT5ULdgaPdncPtaRITOCRaIPJJOK-1RkDjxjXtfvI61aknREOnLBOFtC51KrXKZaYQiGNs6pwySjteZ0bneXYX1rFx9j6wUhpENtIog28YZ7weoydUqJJrI5UY8xG86H9kpSO7OSXZOK0GL2d-UvkPPIJng-hZoPT4k9BGrw1VtOplRR48uoeFFCN4OjxGe6RNFtXYdkUyCLiwh1socy9o0VBLJilCrciwsV4X_l59tfdm6i8e_LvoE7gyPdyfVbO3B-8ewlVO5zR83M0GrHfnK_sI0VNXP_ZG8h25mxcW
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hKiEufQBtt9DiVhx6CSKO403oaUVZlkcRQkXiUCly_FhWRQlis5ee-g_ob-wv6fiRtDwqVb1FyTi2kxn7G3v8DcCGpizNlVYRtVlNGJV5JBhLIiXVlpG85NxH-R7z0Rk7OE_P5-BDexbG80N0C27WMtx4bQ38Spk_jXx8YZdGLOXnI8YRSVhEdPqbO4p5ll2c8tIoR0ULtEIujKctensyuocwbwNWN-MMn8CXtq0-0OTr5qwpN-W3OzSO_9mZp_A4IFEy8KrzDOZ0tQQLn8Je-zLcDMb65_cfbZbchoTQD1Ib0q7YElEpUvvcAqSuyKWN8sBC7oSMVsTRQ03JpCJVXeF94RPyTiQxosEiTp6ETaJtgqOYCCQptpadIxzod23pwXQiVuBsuPt5ZxSF9A2RZIh7IkpLKRHOmH5p9z5pGcvY0aGhS5awjGsTGxFrYRKVMUQxOjZGKCENLRMl0zR5DvPYOP0SSM4V4hquhMI39BNa9tEPykROpeKC9WkP3rf_sZCB29ym2LgsOh9nfFG4D9yDd53olSf0eEhorVWGItj0tLD-OzqHGWc9eNs9Rmu0Wyyi0vXMyiDcwh5uocwLr0RdLQm38WlZgo11qvD36ouDvZG7ePXvouuwcPJxWBztHx-uwiK1hzRc0M0azDfXM_0aoVNTvnEm8gttQBXF
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Age%E2%80%90dependent+effects+of+diabetes+and+obesity+on+liver%E2%80%90related+events+in+non%E2%80%90alcoholic+fatty+liver+disease%3A+Subanalysis+of+CLIONE+in+Asia&rft.jtitle=Journal+of+gastroenterology+and+hepatology&rft.au=Seko%2C+Yuya&rft.au=Kawanaka%2C+Miwa&rft.au=Fujii%2C+Hideki&rft.au=Iwaki%2C+Michihiro&rft.date=2022-12-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0815-9319&rft.eissn=1440-1746&rft.volume=37&rft.issue=12&rft.spage=2313&rft.epage=2320&rft_id=info:doi/10.1111%2Fjgh.16019&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0815-9319&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0815-9319&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0815-9319&client=summon